Fenfluramine and the cytochrome P450 system.
Fogelson
D L
DL
D065607:Cytochrome P-450 Enzyme Inhibitors; D003577:Cytochrome P-450 Enzyme System / Q000187:drug effects*; D004347:Drug Interactions; D005260:Female; D005277:Fenfluramine / Q000009:adverse effects* / Q000493:pharmacokinetics* / Q000494:pharmacology; D006801:Humans; D007099:Imipramine / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology; D008875:Middle Aged; D009765:Obesity / Q000139:chemically induced / Q000188:drug therapy*; D015430:Weight Gain / Q000187:drug effects
D065607:Cytochrome P-450 Enzyme Inhibitors; D005277:Fenfluramine; D003577:Cytochrome P-450 Enzyme System; D007099:Imipramine